Bariatric (Obesity) Surgical Devices

Global Bariatric (Obesity) Surgical Devices Market to Reach US$5.5 Billion by 2030

The global market for Bariatric (Obesity) Surgical Devices estimated at US$3.4 Billion in the year 2024, is expected to reach US$5.5 Billion by 2030, growing at a CAGR of 8.4% over the analysis period 2024-2030. Sleeve Gastrectomy, one of the segments analyzed in the report, is expected to record a 11.4% CAGR and reach US$3.6 Billion by the end of the analysis period. Growth in the Gastric Bypass segment is estimated at 3.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$911.4 Million While China is Forecast to Grow at 7.7% CAGR

The Bariatric (Obesity) Surgical Devices market in the U.S. is estimated at US$911.4 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$834.7 Million by the year 2030 trailing a CAGR of 7.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.0% and 6.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.0% CAGR.

Bariatric (Obesity) Surgical Devices  - Key Trends and Drivers

Bariatric surgery stands out as a highly effective intervention for obesity management, providing substantial and enduring weight loss benefits. This surgical method includes a variety of procedures that modify the gastrointestinal tract to limit food intake and absorption. Among the well-established techniques are sleeve gastrectomy, gastric bypass, adjustable gastric banding, and biliopancreatic diversion with duodenal switch, each backed by a solid history of success. Meanwhile, newer methods such as intragastric balloons, the AspireAssist device, and endoscopic sleeve gastroplasty are gaining attention, though they require more research to fully understand their long-term efficacy.

The bariatric surgical devices market is poised for continued growth, fueled by the escalating global obesity crisis, technological advancements in medical procedures, broader acceptance of surgical solutions, and an expanding support framework through insurance. These factors, combined with ongoing innovations in minimally invasive technologies and robotic-assisted surgeries, are shaping a dynamic market environment where patient outcomes and surgical efficiency are steadily improving. The growing awareness and acceptance of bariatric surgery as a viable and safe option for weight loss contribute to its market growth. Educational efforts by health organizations and medical communities have helped demystify the procedures and highlight their benefits, encouraging more patients to consider this option. Moreover, the social stigma associated with surgical weight loss is diminishing, further fueling the market expansion.

Technological advancements have significantly enhanced the safety, efficacy, and outcomes of bariatric surgeries. Innovations such as minimally invasive techniques and robotic-assisted surgery offer improved precision and patient comfort, leading to shorter hospital stays and fewer complications. Moreover, the integration of robotics and digital solutions is optimizing patient care pathways, with artificial intelligence playing a pivotal role in predictive analytics, personalized treatment plans, and enhanced postoperative care. The trend towards personalized medicine is influencing the bariatric surgery space, emphasizing tailored surgical interventions based on individual patient needs and biological profiles. This patient-centric approach fosters continual innovation in surgical techniques and device development, catering to a broader range of anatomies and patient conditions.

SCOPE OF STUDY:

The report analyzes the Bariatric (Obesity) Surgical Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Segment (Sleeve Gastrectomy, Gastric Bypass, Gastric Banding, Other Segments)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 26 Featured) -

• Agency for Medical Innovations GmbH
• Apollo Endosurgery Inc.
• Bariatric Solutions GmBH
• Cousin Biotech
• Ethicon US LLC
• Helioscopie SA
• Médical Innovation Développement
• Medtronic Plc

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.